Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standard…
Ars Technica reports: Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standard treatment in a late-stage trial, pharmaceutical partners Merck and Moderna announced Thursday.
The results are a significant advance in melanoma treatment; Merck and Moderna are already engaging with regulatory authorities to get the vaccine approved.
This health story centres on the United States. Names and organisations mentioned in the coverage include Merck and Moderna.
Why it matters
Health developments can affect patients, healthcare providers and public-health planning.
Key details
- Location
- United States · Americas
- Reported by
- Ars Technica
- First reported
- Key names
- Merck, Moderna
- Section
- Health
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at Ars TechnicaSpotted an error? Request a correction · How this summary was produced
Related Stories
Moderna shares plunge after leak of cancer vaccine data despite positive results
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
Why painful arthritis can return stronger after cancer treatment
Researchers discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember previous attacks and…
A protein that fuels cancer could also be the key to fighting it
Scientists have discovered how to turn a protein that normally fuels cancer growth into a weapon against it.
Bowel cancer “melted away” after immunotherapy, then stayed away
A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer.
Flu cases rise on west coast earlier than usual as US health experts encourage vaccine
California flu test rate at 9.65%, higher than normal 1% rate for early October, amid mutation of H1N1 influenza A strain Flu cases on the west…
I thought I was dying but it was health anxiety - here's how to recognise the signs
Hollie Sharman shares her experience of health anxiety and a doctor advises on how to manage symptoms.
Give more people weight loss jabs on the NHS, say MPs
Current plans for 6% of eligible patients to get Mounjaro by 2028 unambitious, say MPs.
Haematology centre for cancer patients at risk over 'disgraceful' funds move
The Department of Health has decided to take back £1.5m from the project, Belfast Trust officials have told a Stormont committee.